Welcome to the House Committee on Energy and Commerce

E&C is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care.

Established

December 14, 1795

30

Members

6

specialized subcommittees

The Latest

From the Committee

Aug 27, 2026

Press Release

Chairmen Guthrie and Palmer Announce Legislative Hearing to Safeguard America’s Drinking Water

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, announced a hearing titled “Reliable Water in the Digital Age: Examining Legislation to Strengthen Drinking Water Systems and Protect Ratepayers.”

“Throughout this Congress, the Committee has worked to ensure Americans have access to safe and reliable drinking water,” said Chairmen Guthrie and Palmer. “This hearing will provide an opportunity for members to discuss legislation that safeguards our drinking water infrastructure, protecting water systems against cyber threats and other risks. Further, we will consider draft legislation to ensure that data center builders, and not American families, are responsible for the water that their infrastructure requires.”

Subcommittee on Environment hearing titled Reliable Water in the Digital Age: Examining Legislation to Strengthen Drinking Water Systems and Protect Ratepayers

WHAT: Subcommittee on Environment hearing to discuss legislation that would ensure the safety and reliability of drinking water in communities across the country.

DATE: Thursday, September 3, 2026

TIME: 9:00 AM ET

LOCATION: 2123 Rayburn House Office Building

Items to be considered:

H.R. ____, [Safe Drinking Water Infrastructure Improvement Act of 2026]
H.R. ____, [Water Cost Accountability Act of 2026]

This notice is at the direction of the Chairman. The hearing will be open to the public and press and will be livestreamed online at energycommerce.house.gov. If you have any questions concerning this hearing, please contact Seth Ricketts with the Committee staff at Seth.Ricketts@mail.house.gov. If you have any press-related questions, please contact Ben Mullany at Ben.Mullany@mail.house.gov.

More News & Announcements

Aug 13, 2026

Health

New HHS Report Depicts How the Working Families Tax Cuts Lowers Health Insurance Premiums and Hospital Prices for Americans

WASHINGTON, D.C. - This week, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report, finding provider tax and state-directed payment policies in the Working Families Tax Cuts (WFTC) are expected to reduce health care prices by up to 3.5 percent and reduce costs in Medicaid, commercial insurance, and Medicare—noting an additional $29 billion in savings for Medicare and commercial coverage for every $100 billion in Medicaid savings. Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, issued the following statement in response to ASPE's findings:

"Despite Democrat rhetoric, evidence continues to show that our Working Families Tax Cuts will protect patients by not only restoring the long-term security of the Medicaid program, but also lowering costs for patients. By ending abuses of financing gimmicks, we help save taxpayer dollars and ensure federal funding is being used for the most vulnerable.

"It's no secret that the abuse of provider tax schemes and state directed payment arrangements had become an open-ended checkbook for states to shift more and more costs to the federal government, driving unsustainable and unaccountable growth in the Medicaid program. In a new report released by the Department of Health and Human Services, not only will these policies safeguard the Medicaid program and its beneficiaries but will also lower health care prices by 3.5 percent and reduce health care spending for Americans with private commercial insurance and Medicare. Because of Republicans' commonsense policies, we are protecting our most vulnerable and lowering health care costs for all Americans," said Charimen Guthrie and Griffith

BACKGROUND:

Last year, the House Committee on Energy and Commerce rooted out over a trillion dollars of waste, fraud, and abuse through policies that strengthen, secure, and sustain our Medicaid program.
Health care provider taxes have been used to fund Medicaid supplemental payments like state-directed payments (SDPs), drawing down additional federal Medicaid funding to support higher provider rates without additional expenditures from state general funds.
SDPs increased considerably during the Biden Administration, with managed care organizations receiving $43 billion in payments in 2021-an amount that more than tripled to $144 billion by 2025.
Without the WFTC, payments were expected to exceed $300 billion by 2034.
By 2025, the average service covered by an SDP was compensated at 186 percent of the Medicare rate, meaning often we were paying significantly more to care for able-bodied adults than our seniors.
Policies in the WFTC that reduce the abuse of provider taxes and SDP gimmicks are projected to reduce non-Medicaid prices by up to 3.5 percent, benefiting non-Medicaid payers by $502 billion to $875 billion from 2025-2034.
Once fully phased in, these policies are expected to lower annual health care spending by $100 billion to $175 billion.
Some of the savings to non-Medicaid payers also accrue to the federal government, saving an additional $97 billion to $169 billion beyond its savings on Medicaid and reducing total federal health spending by an average of 2.9 percent to 5.1 percent, when fully phased in.
This isn't just savings for taxpayers; ASPE projects the changes to provider taxes and state directed payments under the WFTC could lead to reduced premiums in commercial insurance markets, making employer-sponsored insurance and Marketplace coverage more affordable for Americans than they would have been without the WFTC.

Read additional coverage on this report HERE.

Aug 5, 2026

Press Release

Chairmen Guthrie and Joyce on the Decertification of Kentucky OPO Following Months of Congressional Oversight

WASHINGTON, D.C. - Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, issued the following statements following the Department of Health and Human Services' (HHS) decision to decertify Network for Hope - the Organ Procurement Organization (OPO) covering Kentucky and parts of Ohio, West Virginia, and Indiana.

"Thanks to the steadfast oversight efforts of Secretary Kennedy and our robust oversight on the House Committee on Energy and Commerce, decisive action has been taken to protect American patients and families," said Chairman Guthrie. "We have conducted rigorous oversight of the alarming practices in our organ procurement and transplantation system, and the American people deserve to have an organ procurement and transplantation system that they can trust. This action takes a step forward in restoring integrity back to that system."

"Serious deficiencies in Network for Hope's organ procurement process were brought to light through the work of our Oversight and Investigations Subcommittee," said Chairman John Joyce, M.D. "Despite subsequent efforts by HHS to address these issues, concerns remain about Network for Hope's ability to safely carry out its duties as an OPO. Therefore, I applaud HHS for taking decisive action to initiate the decertification process against the organization. I want to express my gratitude to Secretary Kennedy, Administrator Engels, and Administrator Oz for their attention to this important issue and their recognition of this necessary action following our oversight efforts, including last year's hearing that centered on our concerns regarding Network for Hope. As the process moves forward, I urge Network for Hope to fully cooperate with HHS to ensure that patients and their safety are prioritized throughout the decertification process and the selection of a new OPO to take over Network for Hope's donor service area."

BACKGROUND:

During the 118th Congress, the Committee on Energy and Commerce led the passage of the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the Organ Procurement and Transplantation Network (OPTN) and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.
On March 20, 2024, the Committee launched an investigation into the organ procurement and transplantation system by sending a letter to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.
On March 20, 2024, the Committee also sent a letter to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.
On September 11, 2024, the Subcommittee on Oversight and Investigations held a hearing that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.
During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA's March 2025 report.
On March 24, 2025, HRSA's Division of Transplantation issued a report that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virginia, and Indiana.
HRSA's investigation examined an "index case" and an additional 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for donation after circulatory death recovery, but no organs were transplanted. The report showed that nearly 30 percent of the cases "had concerning features." The concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.
On May 28, 2025, HRSA issued a corrective action plan to the OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.
On July 22, 2025, the House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation's organ procurement and transplant system that were identified by HRSA's investigation.
On September 12, 2025, the Committee sent a bipartisan letter to the HRSA requesting a briefing on its ongoing oversight of patient safety in our nation's organ procurement and transplant system.
On November 17, 2025, Chairmen Guthrie and Joyce sent a letter to CMS requesting a briefing to better understand HHS' recent actions and ongoing work to enhance safety within the organ procurement and transplantation system.

Jul 29, 2026

Press Release

Congressional Leaders Get Answers from CBO on Unbudgeted IRA Costs and Multibillion-Dollar Spending Revisions

WASHINGTON, D.C. - Today, the Congressional Budget Office (CBO) responded to a May 20, 2026 letter, authored by Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Jason Smith (MO-08), Chairman of the House Committee on Ways and Means, and Congressman Jodey Arrington (TX-19), Chairman of the House Committee on the Budget, seeking further explanation for CBO's dramatic upward revision of Medicare Part D spending. Chairmen Guthrie, Smith, and Arrington issued the following statements in response to CBO's findings:

"Earlier this year, CBO's baseline update projected significantly higher costs for Medicare Part D, including an estimated $700 billion in additional Medicare prescription drug spending over the next decade," said Chairman Guthrie. "In response to the May letter I sent, alongside Chairmen Arrington and Smith, CBO highlighted how the problematic design of the Inflation Reduction Act (IRA) has not led to the savings CBO originally projected but has instead led to increased costs for taxpayers and instability in the Part D marketplace. The Part D program is critical to meeting seniors' needs and requires durable regulatory policies to ensure the long-term affordability and availability of prescription drug plans for these beneficiaries."

"Washington Democrats' Inflation Expansion Act was yet another costly promise that failed to deliver lower prices for seniors. Democrats promised lower prescription drug prices, but the Congressional Budget Office is once again confirming that their policies instead increased costs for America's seniors and taxpayers by an additional $700 billion while offering 50% fewer drug plans for them to choose from. Plain and simple, Democrats have made it harder for seniors to afford prescription drugs," said Chairman Smith. "Because of these misguided policies, Americans are paying more for health care than ever before while facing fewer choices and less access to care in return. Meanwhile, powerful health care empires continue to benefit from government-created distortions, loopholes, and misaligned incentives that reward higher spending instead of better outcomes. The Ways and Means Committee will continue fighting to hold these empires accountable, expand access to care, and lower costs - not help powerful interests that have benefited from the status quo."

"The Congressional Budget Office's (CBO) new analysis confirms what Republicans sounded the alarm on for years: The drug pricing scheme in the Inflation Reduction Act fails to deliver the savings Democrats promised. CBO originally estimated these policies would save taxpayers $129 billion. Instead, CBO now confirms the IRA's misguided policies were the major driver behind higher projected Part D expenditures, contributing to a $700 billion deficit increase," said Chairman Arrington. "We have once again confirmed that Democrats, with CBO's analysis in hand, sold the American people a false bill of goods in the Inflation Reduction Act. Combined with the Joint Committee on Taxation's $600 billion miscalculation of the cost of the Green New Deal tax credits, we now know the IRA cost Americans $1.3 trillion more in new deficit spending. Today, taxpayers are left holding the bag due to Democrats' failed experiment in price fixing and their green new deal climate agenda."

BACKGROUND:

On May 20, 2026, Chairmen Guthrie, Smith, and Arrington penned a letter to CBO regarding its updated scoring of the IRA and updated Part D outlay projections.
This revision includes an approximately $700 billion increase in projected Medicare Part D outlays and shows that Part D spending per beneficiary in 2035 is now projected to be more than $4,000.
The Government Accountability Office (GAO) confirmed that the Biden-Harris administration's "Premium Stabilization Demonstration" under Medicare spent $9.8 billion on premium stabilization.
On July 28, 2026, the Centers for Medicare & Medicaid Services announced the conclusion of the Part D Premium Stabilization Demonstration, discontinuing the demonstration at the end of CY 2026 to return the program to operating under traditional market conditions in CY 2027.
On July 29, 2026, CBO responded to the Congressional leaders' inquiry, providing additional information on CBO's original estimates and current projections of the drug pricing provisions enacted in the IRA, as well as projections about Part D spending growth in the next decade.
According to the Medicare Payment Advisory Commission (MedPAC), the average number of stand-alone prescription drug plans available to beneficiaries in 2025 was 14, the lowest number since Part D began.
MedPAC has also noted a decline in recent years in the average number of benchmark plans, which are $0 premium plan options for beneficiaries receiving the low-income subsidy.

Trending Subcommittees

Full Committee

Energy

National Energy Policy, energy infrastructure and security, energy related Agencies and Commissions, all laws, programs, and government activities affecting energy matters. National Energy Policy focuses on fossil energy; renewable energy; nuclear energy; energy conservation, utility issues, including but not limited to interstate energy compacts; energy generation, marketing, reliability, transmission, siting, exploration, production, efficiency, cybersecurity, and ratemaking for all generated power. Energy infrastructure and security focuses on pipelines, the strategic petroleum reserve, nuclear facilities, and cybersecurity for our nation’s grid. Our jurisdiction also includes all aspects of the above-referenced jurisdiction related to the Department of Homeland Security. Agencies and Commissions in our jurisdiction include: The US Department of Energy, the Nuclear Regulatory Commission; and the Federal Energy Regulatory Commission.

Commerce, Manufacturing, and Trade

Interstate and foreign commerce, including all trade matters within the jurisdiction of the full committee; consumer protection, including privacy matters generally; data security; motor vehicle safety; regulation of commercial practices (the Federal Trade Commission), including sports-related matters; consumer product safety (the Consumer Product Safety Commission); product liability; and regulation of travel, tourism, and time. The Subcommittee’s jurisdiction can be directly traced to Congress’ constitutional authority “to regulate Commerce with foreign nations, and among the several States, and with the Indian Tribes.”

Communications & Technology

Electronic communications, both Interstate and foreign, including voice, video, audio and data, whether transmitted by wire or wirelessly, and whether transmitted by telecommunications, commercial or private mobile service, broadcast, cable, satellite, microwave, or other mode; technology generally; emergency and public safety communications; cybersecurity, privacy, and data security; the Federal Communications Commission, the National Telecommunications and Information Administration, the Office of Emergency Communications in the Department of Homeland Security; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Environment

1 Update

All matters related to soil, air, noise and water contamination; emergency environmental response, both physical and cybersecurity. In particular, the subcommittee has jurisdiction over The Nuclear Waste Policy Act, The Clean Air Act, The Safe Drinking Water Act, Comprehensive Environmental Response Compensation and Liability Act – including Superfund and the Emergency Planning and Community Right to Know Act, The Solid Waste Disposal Act, The Toxic Substance Control Act and The Chemical Facility Anti-Terrorism Standards Program. Under the Clean Air Act, this subcommittee deals with National Ambient Air Quality Standards (NAAQS) for criteria pollutants; National Emissions Standards for Hazardous Air Pollutants (NESHAP) Standards; New Source Performance Standards (NSPS); Mobile Source Standards for vehicles, aircraft, fuels and fuel additives, including the Renewable Fuel Standard (RFS) and greenhouse gas emissions from motor vehicles. The subcommittee focuses on the regulation of solid, hazardous, and nuclear wastes, including mining, nuclear, oil, gas, and coal combustion waste.

Health

2 Updates

The health sector broadly, including private and public health insurance (Patient Protection and Affordable Care Act, Medicare, Medicaid, CHIP); biomedical research and development; hospital construction; mental health; health information technology, privacy, and cybersecurity; medical malpractice and medical malpractice insurance; the 340B drug discount program; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Oversight & Investigations

1 Update

Responsible for conducting oversight and investigations of any matter related to the jurisdiction of the full committee.

Recent Letters

Aug 13, 2026

Health

New HHS Report Depicts How the Working Families Tax Cuts Lowers Health Insurance Premiums and Hospital Prices for Americans

BACKGROUND:

Last year, the House Committee on Energy and Commerce rooted out over a trillion dollars of waste, fraud, and abuse through policies that strengthen, secure, and sustain our Medicaid program.
Health care provider taxes have been used to fund Medicaid supplemental payments like state-directed payments (SDPs), drawing down additional federal Medicaid funding to support higher provider rates without additional expenditures from state general funds.
SDPs increased considerably during the Biden Administration, with managed care organizations receiving $43 billion in payments in 2021-an amount that more than tripled to $144 billion by 2025.
Without the WFTC, payments were expected to exceed $300 billion by 2034.
By 2025, the average service covered by an SDP was compensated at 186 percent of the Medicare rate, meaning often we were paying significantly more to care for able-bodied adults than our seniors.
Policies in the WFTC that reduce the abuse of provider taxes and SDP gimmicks are projected to reduce non-Medicaid prices by up to 3.5 percent, benefiting non-Medicaid payers by $502 billion to $875 billion from 2025-2034.
Once fully phased in, these policies are expected to lower annual health care spending by $100 billion to $175 billion.
Some of the savings to non-Medicaid payers also accrue to the federal government, saving an additional $97 billion to $169 billion beyond its savings on Medicaid and reducing total federal health spending by an average of 2.9 percent to 5.1 percent, when fully phased in.
This isn't just savings for taxpayers; ASPE projects the changes to provider taxes and state directed payments under the WFTC could lead to reduced premiums in commercial insurance markets, making employer-sponsored insurance and Marketplace coverage more affordable for Americans than they would have been without the WFTC.

Read additional coverage on this report HERE.

Aug 5, 2026

Press Release

Chairmen Guthrie and Joyce on the Decertification of Kentucky OPO Following Months of Congressional Oversight

BACKGROUND:

During the 118th Congress, the Committee on Energy and Commerce led the passage of the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the Organ Procurement and Transplantation Network (OPTN) and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.
On March 20, 2024, the Committee launched an investigation into the organ procurement and transplantation system by sending a letter to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.
On March 20, 2024, the Committee also sent a letter to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.
On September 11, 2024, the Subcommittee on Oversight and Investigations held a hearing that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.
During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA's March 2025 report.
On March 24, 2025, HRSA's Division of Transplantation issued a report that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virginia, and Indiana.
HRSA's investigation examined an "index case" and an additional 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for donation after circulatory death recovery, but no organs were transplanted. The report showed that nearly 30 percent of the cases "had concerning features." The concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.
On May 28, 2025, HRSA issued a corrective action plan to the OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.
On July 22, 2025, the House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation's organ procurement and transplant system that were identified by HRSA's investigation.
On September 12, 2025, the Committee sent a bipartisan letter to the HRSA requesting a briefing on its ongoing oversight of patient safety in our nation's organ procurement and transplant system.
On November 17, 2025, Chairmen Guthrie and Joyce sent a letter to CMS requesting a briefing to better understand HHS' recent actions and ongoing work to enhance safety within the organ procurement and transplantation system.

Jul 29, 2026

Press Release

Congressional Leaders Get Answers from CBO on Unbudgeted IRA Costs and Multibillion-Dollar Spending Revisions

BACKGROUND:

On May 20, 2026, Chairmen Guthrie, Smith, and Arrington penned a letter to CBO regarding its updated scoring of the IRA and updated Part D outlay projections.
This revision includes an approximately $700 billion increase in projected Medicare Part D outlays and shows that Part D spending per beneficiary in 2035 is now projected to be more than $4,000.
The Government Accountability Office (GAO) confirmed that the Biden-Harris administration's "Premium Stabilization Demonstration" under Medicare spent $9.8 billion on premium stabilization.
On July 28, 2026, the Centers for Medicare & Medicaid Services announced the conclusion of the Part D Premium Stabilization Demonstration, discontinuing the demonstration at the end of CY 2026 to return the program to operating under traditional market conditions in CY 2027.
On July 29, 2026, CBO responded to the Congressional leaders' inquiry, providing additional information on CBO's original estimates and current projections of the drug pricing provisions enacted in the IRA, as well as projections about Part D spending growth in the next decade.
According to the Medicare Payment Advisory Commission (MedPAC), the average number of stand-alone prescription drug plans available to beneficiaries in 2025 was 14, the lowest number since Part D began.
MedPAC has also noted a decline in recent years in the average number of benchmark plans, which are $0 premium plan options for beneficiaries receiving the low-income subsidy.